Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression

• Published in: Biomolecules (Basel, Switzerland) Switzerland), 2020-03, Vol.10 (4), p.507
• Main Authors: Siniavin, Andrei E, Streltsova, Maria A, Kudryavtsev, Denis S, Shelukhina, Irina V, Utkin, Yuri N, Tsetlin, Victor I
• Format: Article
• Language: English
• Subjects: Acetylcholine receptors (nicotinic); Adaptive immunity; Adaptive Immunity - drug effects; Adaptive Immunity - physiology; alpha7 Nicotinic Acetylcholine Receptor - genetics; alpha7 Nicotinic Acetylcholine Receptor - immunology; alpha7 Nicotinic Acetylcholine Receptor - metabolism; Antigens; Bacterial infections; Benzamides - pharmacology; Bridged Bicyclo Compounds - pharmacology; Bungarotoxin; Calcium currents; CD11b antigen; CD14 antigen; Cell activation; Cell adhesion & migration; Cloning; Cytokines; Cytokines - metabolism; Cytoplasm; Gram-positive bacteria; Histocompatibility antigen HLA; HLA-DR Antigens - immunology; Homeostasis; Humans; Immune response; Immune system; Immune Tolerance - drug effects; Immune Tolerance - immunology; Immunosuppression; Inflammation; innate immunity; Interleukin 10; Interleukin-10 - metabolism; Ion currents; Kinases; Lipopolysaccharide Receptors - metabolism; Lipopolysaccharides - metabolism; Lipopolysaccharides - pharmacology; Macrophages; Macrophages - drug effects; Macrophages - metabolism; Monocytes; Nicotinic Agonists - pharmacology; Patch-Clamp Techniques; Sepsis; Software; Therapeutic targets; THP-1 Cells; Tumor necrosis factor-TNF; Tumor necrosis factor-α; α7 nAChR
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom10040507

Immune response during sepsis is characterized by hyper-inflammation followed by immunosuppression. The crucial role of macrophages is well-known for both septic stages, since they are involved in immune homeostasis and inflammation, their dysfunction being implicated in immunosuppression. The cholinergic anti-inflammatory pathway mediated by macrophage α7 nicotinic acetylcholine receptor (nAChR) represents possible drug target. Although α7 nAChR activation on macrophages reduces the production of proinflammatory cytokines, the role of these receptors in immunological changes at the cellular level is not fully understood. Using α7 nAChR selective agonist PNU 282,987, we investigated the influence of α7 nAChR activation on the expression of cytokines and, for the first time, of the macrophage membrane markers: cluster of differentiation 14 (CD14), human leukocyte antigen-DR (HLA-DR), CD11b, and CD54. Application of PNU 282,987 to THP-1Mϕ (THP-1 derived macrophages) cells led to inward ion currents and Ca increase in cytoplasm showing the presence of functionally active α7 nAChR. Production of cytokines tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and IL-10 was estimated in classically activated macrophages (M1) and treatment with PNU 282,987 diminished IL-10 expression. α7 nAChR activation on THP-1Mϕ, THP-1M1, and monocyte-derived macrophages (MDMs) increased the expression of HLA-DR, CD54, and CD11b molecules, but decreased CD14 receptor expression, these effects being blocked by alpha (α)-bungarotoxin. Thus, PNU 282,987 enhances the macrophage-mediated immunity via α7 nAChR by regulating expression of their membrane receptors and of cytokines, both playing an important role in preventing immunosuppressive states.